M. Feely

1.6k total citations
40 papers, 1.2k citations indexed

About

M. Feely is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Feely has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 13 papers in Psychiatry and Mental health and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Feely's work include Epilepsy research and treatment (11 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). M. Feely is often cited by papers focused on Epilepsy research and treatment (11 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Neuroscience and Neuropharmacology Research (5 papers). M. Feely collaborates with scholars based in United Kingdom, Ireland and Canada. M. Feely's co-authors include T Pullar, Jeremy R.M. Haigh, John S. Gibson, J P Gent, Alistair Hay, N. Callaghan, A. Guberman, A. J. Birtwell, Pamela Crawford and Philip Wiles and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Annals of the Rheumatic Diseases and Thorax.

In The Last Decade

M. Feely

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Feely United Kingdom 19 412 361 166 155 147 40 1.2k
Geneviève Durrieu France 24 320 0.8× 191 0.5× 185 1.1× 109 0.7× 158 1.1× 105 1.7k
William R. Garnett United States 22 791 1.9× 701 1.9× 63 0.4× 134 0.9× 66 0.4× 84 1.6k
Alberto Vaccheri Italy 25 124 0.3× 145 0.4× 229 1.4× 231 1.5× 187 1.3× 74 1.5k
Timothy E. Welty United States 17 421 1.0× 346 1.0× 170 1.0× 112 0.7× 52 0.4× 53 1.1k
François Montastruc France 29 261 0.6× 431 1.2× 147 0.9× 91 0.6× 253 1.7× 145 2.3k
B.‐E. Wiholm Sweden 23 233 0.6× 113 0.3× 80 0.5× 53 0.3× 104 0.7× 35 1.7k
Joan‐Ramon Laporte Spain 26 279 0.7× 107 0.3× 152 0.9× 60 0.4× 310 2.1× 86 2.0k
A. J. Porsius Netherlands 17 143 0.3× 134 0.4× 178 1.1× 52 0.3× 296 2.0× 56 1.4k
Michael E. Pitterle United States 22 428 1.0× 279 0.8× 97 0.6× 58 0.4× 31 0.2× 46 1.1k
P. K. M. Lunde Norway 24 326 0.8× 198 0.5× 68 0.4× 64 0.4× 142 1.0× 52 1.3k

Countries citing papers authored by M. Feely

Since Specialization
Citations

This map shows the geographic impact of M. Feely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Feely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Feely more than expected).

Fields of papers citing papers by M. Feely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Feely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Feely. The network helps show where M. Feely may publish in the future.

Co-authorship network of co-authors of M. Feely

This figure shows the co-authorship network connecting the top 25 collaborators of M. Feely. A scholar is included among the top collaborators of M. Feely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Feely. M. Feely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Callaghan, N., M. Feely, Michael O’Callaghan, et al.. (2009). THE EFFECTS OF TOXIC AND NON-TOXIC SERUM PHENYTOIN LEVELS ON CARBOHYDRATE TOLERANCE AND INSULIN LEVELS. Acta Neurologica Scandinavica. 56(6). 563–571. 2 indexed citations
3.
Crawford, Pamela, M. Feely, A. Guberman, & Günter Krämer. (2006). Are there potential problems with generic substitution of antiepileptic drugs?. Seizure. 15(3). 165–176. 110 indexed citations
4.
Feely, M.. (1999). Drug treatment of epilepsy. BMJ. 318(7176). 106–109. 28 indexed citations
5.
Karbwang, Juntra, et al.. (1998). Initial evaluation of low-dose phenobarbital as an indicator of compliance with antimalarial drug treatment.. PubMed. 76 Suppl 1. 67–73. 6 indexed citations
6.
Feely, M.. (1994). ABC of monitoring drug therapy. British Journal of Clinical Pharmacology. 37(1). 103–104. 2 indexed citations
7.
Cooke, John P., et al.. (1992). The influence of an academic representative on prescribing by general practitioners.. British Journal of Clinical Pharmacology. 33(1). 69–73. 38 indexed citations
8.
Haigh, Jeremy R.M., et al.. (1990). Effect of warfarin on plasma concentrations of vitamin K dependent coagulation factors in patients with stable control and monitored compliance. British Journal of Haematology. 74(1). 82–85. 32 indexed citations
9.
Mehta, A. C., et al.. (1989). Measurement of low (sub-therapeutic) phenobarbitone levels in plasma by high-performance liquid chromatography: application to patient compliance studies. Journal of Chromatography B Biomedical Sciences and Applications. 497. 308–312. 7 indexed citations
10.
Pullar, T, et al.. (1989). PATIENTS‘ KNOWLEDGE CONCERNING THEIR MEDICATIONS ON DISCHARGE FROM HOSPITAL. Journal of Clinical Pharmacy and Therapeutics. 14(1). 57–59. 21 indexed citations
11.
Griffiths, A P, et al.. (1988). Use of a pharmacological indicator to monitor compliance with thyroxine. European Journal of Clinical Pharmacology. 35(3). 327–329. 7 indexed citations
12.
Pullar, T, et al.. (1988). THE USE OF A PHARMACOLOGICAL INDICATOR TO INVESTIGATE COMPLIANCE IN PATIENTS WITH A POOR RESPONSE TO ANTIRHEUMATIC THERAPY. Lara D. Veeken. 27(5). 381–384. 51 indexed citations
13.
Pullar, T, A. J. Birtwell, Philip Wiles, Alistair Hay, & M. Feely. (1988). Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clinical Pharmacology & Therapeutics. 44(5). 540–545. 140 indexed citations
14.
Pullar, T, et al.. (1987). Pharmacokinetics of N‐desmethylclobazam in healthy volunteers and patients with epilepsy.. British Journal of Clinical Pharmacology. 24(6). 793–797. 16 indexed citations
15.
Cooke, Jonathan, et al.. (1986). Doctors' unawareness of the drugs their patients are taking: a major cause of overprescribing?. BMJ. 292(6513). 99–100. 54 indexed citations
16.
Feely, M., et al.. (1984). The Inadequacies of Information on Current Drug Therapy in Out-Patients' Records. Journal of the Royal College of Physicians of London. 18(4). 222–224. 8 indexed citations
17.
Feely, M., et al.. (1984). Use of Low-Dose Phenobarbitone to Assess Patient Compliance. Clinical Science. 67(s9). 28P–28P. 1 indexed citations
18.
Feely, M. & John S. Gibson. (1984). Intermittent clobazam for catamenial epilepsy: tolerance avoided.. Journal of Neurology Neurosurgery & Psychiatry. 47(12). 1279–1282. 68 indexed citations
19.
Feely, M., et al.. (1982). Episodes of acute confusion or psychosis in familial hemiplegic migraine. Acta Neurologica Scandinavica. 65(4). 369–375. 32 indexed citations
20.
O’Callaghan, Michael, N. Callaghan, M. Feely, & Patrick Duggan. (1977). Measurement of anti-epileptic drugs in plasma by gas-liquid chromatography. Irish Journal of Medical Science (1971 -). 146(1). 245–254. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Durrieu Breakdown of academic impact, for papers by William R. Garnett Breakdown of academic impact, for papers by Alberto Vaccheri Breakdown of academic impact, for papers by Timothy E. Welty Breakdown of academic impact, for papers by François Montastruc Breakdown of academic impact, for papers by B.‐E. Wiholm Breakdown of academic impact, for papers by Joan‐Ramon Laporte Breakdown of academic impact, for papers by A. J. Porsius Breakdown of academic impact, for papers by Michael E. Pitterle Breakdown of academic impact, for papers by P. K. M. Lunde
Rankless by CCL
2026